), can help to explain why KIF15 is ready to aid resistance to Eg5 inhibitors in vivo. MT gliding powered by both equally of these mitotic motors was arrested only whenever they were separately inhibited, lending guidance into the proposal that a combination drug therapy focusing on these motors cou